VolitionRX Forecast, price target & analysts
VolitionRX Target price 2025 - Analyst rating & recommendation
VolitionRX Classifications & Recommendation:
VolitionRX Price Target
| Target Price | $3.34 |
| Price | $0.64 |
| Potential |
422.53%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target VolitionRX 2026 .
The average VolitionRX target price is $3.34.
This is
422.53%
register free of charge
$5.00
682.23%
register free of charge
$2.00
212.89%
register free of charge
|
|
| A rating was issued by 3 analysts: 2 Analysts recommend VolitionRX to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the VolitionRX stock has an average upside potential 2026 of
422.53%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.78 | 1.46 |
| 151.61% | 86.79% | |
| Net Margin | -5,922.44% | -1,986.88% |
| 63.87% | 66.45% |
4 Analysts have issued a sales forecast VolitionRX 2024 . The average VolitionRX sales estimate is
This results in the following potential growth metrics:
3 VolitionRX Analysts have issued a net profit forecast 2024. The average VolitionRX net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.50 | -0.31 |
| 9.09% | 38.00% | |
| P/E | negative | |
| EV/Sales | 41.65 |
3 Analysts have issued a VolitionRX forecast for earnings per share. The average VolitionRX <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the VolitionRX stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current VolitionRX Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| D. Boral Capital | Locked ➜ Locked | Locked | Feb 06 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Jan 29 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Jan 08 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Dec 10 2024 |
| Benchmark | Locked ➜ Locked | Locked | Nov 22 2024 |
| D. Boral Capital | Locked ➜ Locked | Locked | Nov 15 2024 |
| EF Hutton | Locked ➜ Locked | Locked | Nov 01 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Feb 06 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Jan 29 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Jan 08 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Dec 10 2024 |
|
Locked
Benchmark: Locked ➜ Locked
|
Nov 22 2024 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Nov 15 2024 |
|
Locked
EF Hutton: Locked ➜ Locked
|
Nov 01 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
